德源药业
(832735)
| 流通市值：40.53亿 | | | 总市值：45.82亿 |
| 流通股本：1.04亿 | | | 总股本：1.17亿 |
| 报告期 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 一、营业总收入 | 524,548,802.11 | 255,089,983.62 | 868,464,593.56 | 652,939,581.37 |
| 营业收入 | 524,548,802.11 | 255,089,983.62 | 868,464,593.56 | 652,939,581.37 |
| 二、营业总成本 | 404,950,379.68 | 194,770,581.21 | 682,130,948.16 | 524,560,221.68 |
| 营业成本 | 84,810,769.43 | 35,733,172.62 | 134,078,358.92 | 102,069,349.7 |
| 税金及附加 | 7,671,880.44 | 3,908,689.55 | 11,592,085.61 | 9,378,212.45 |
| 销售费用 | 226,537,534.56 | 111,326,869.14 | 370,764,293.46 | 281,352,036.55 |
| 管理费用 | 25,339,417.35 | 14,118,372.14 | 53,950,362.76 | 37,474,511.51 |
| 研发费用 | 60,793,134.18 | 29,736,386.85 | 116,964,755.38 | 97,810,466.84 |
| 财务费用 | -202,356.28 | -52,909.09 | -5,218,907.97 | -3,524,355.37 |
| 其中:利息费用 | 383,823.25 | 198,911.1 | 799,771.22 | 572,516.42 |
| 其中:利息收入 | 621,753.76 | 270,722.81 | 6,075,459.31 | 4,142,878.61 |
| 三、其他经营收益 | | | | |
| 加:公允价值变动收益 | 386,739.73 | 1,181,411.43 | 66,684.93 | 396,465.74 |
| 加:投资收益 | 4,210,611.07 | 1,214,748.75 | 4,739,100.37 | 2,811,381.76 |
| 资产减值损失(新) | -1,181,992.82 | - | - | - |
| 信用减值损失(新) | -1,296,583.96 | -731,392.44 | -805,383.05 | -1,452,002.44 |
| 其他收益 | 2,336,797.84 | 1,297,979.33 | 8,612,443.19 | 6,566,654.08 |
| 四、营业利润 | 124,053,994.29 | 63,282,149.48 | 198,946,490.84 | 136,701,858.83 |
| 加:营业外收入 | 191,613.59 | 156,290.13 | 409,534.94 | 325,969.6 |
| 减:营业外支出 | 1,766,790.5 | 1,736,379.13 | 1,643,475.79 | 124,624.28 |
| 五、利润总额 | 122,478,817.38 | 61,702,060.48 | 197,712,549.99 | 136,903,204.15 |
| 减:所得税费用 | 24,693,352.38 | 15,259,093.58 | 20,729,126.49 | 21,620,293.55 |
| 六、净利润 | 97,785,465 | 46,442,966.9 | 176,983,423.5 | 115,282,910.6 |
| (一)按经营持续性分类 | | | | |
| 持续经营净利润 | 97,785,465 | 46,442,966.9 | 176,983,423.5 | 115,282,910.6 |
| (二)按所有权归属分类 | | | | |
| 归属于母公司股东的净利润 | 97,785,465 | 46,442,966.9 | 176,983,423.5 | 115,282,910.6 |
| 扣除非经常损益后的净利润 | 95,260,279.47 | 45,941,423.94 | 169,595,109.83 | 108,521,126.26 |
| 七、每股收益 | | | | |
| (一)基本每股收益 | 0.83 | 0.59 | 2.28 | 1.49 |
| (二)稀释每股收益 | 0.83 | 0.59 | 2.28 | 1.49 |
| 九、综合收益总额 | 97,785,465 | 46,442,966.9 | 176,983,423.5 | 115,282,910.6 |
| 归属于母公司股东的综合收益总额 | 97,785,465 | 46,442,966.9 | 176,983,423.5 | 115,282,910.6 |
| 公告日期 | 2025-08-19 | 2025-04-28 | 2025-03-31 | 2024-10-25 |
| 审计意见(境内) | | | 标准无保留意见 | |